雅虎香港 搜尋

登入

搜尋結果

  1. pubmed.ncbi.nlm.nih.gov › 23896581Immunogenicity and safety of three 2010-2011 seasonal ...

    The 2009 influenza A (H1N1) pandemic strain was for the first time included in the 2010-2011 seasonal trivalent influenza vaccine (TIV). We conducted a double-blind, randomized trial in Chinese population to assess the immunogenicity and safety of the 2010-2011 TIV manufactured by GlaxoSmithKline and ….

    • Feng-Ji Luo, Li-Qing Yang, Xing Ai, Yun-Hua Bai, Jiang Wu, Shu-Ming Li, Zheng Zhang, Min Lu, Li Li, ...
    • 2013

  2. www.ncbi.nlm.nih.gov › pmc › articlesAn Advisory Committee Statement: Addendum to the 2010-2011 ...

    2011年9月9日 · NACI’s recommendations for the 2010-2011 season relate to use of four vaccines authorized in Canada that are formulated for intramuscular use: Fluviral ® (GlaxoSmithKline), Vaxigrip ® (Sanofi Pasteur), Agriflu ® (Novartis) and Influvac ® (Abbott).

  3. www.chp.gov.hk › tc › features衞生防護中心 - 季節性流感及肺炎球菌疫苗接種資訊 - Centre for ...

    病毒主要透過呼吸道飛沫傳播，患者會出現發燒、喉嚨痛、咳嗽、頭痛、肌肉疼痛、流鼻水及全身疲倦等症狀。. 患者一般會在2至7天內自行痊癒。. 然而，免疫力較低的人和長者一旦染上流感，可能會出現支氣管炎或肺炎等併發症，嚴重時更可導致死亡。. 健康 ...

  4. en.wikipedia.org › wiki › List_of_seasonal_influenza_vaccinesList of seasonal influenza vaccines - Wikipedia

    Vaxigrip and its quadrivalent formulation Vaxigrip Tetra are split virus inactivated vaccines made by Sanofi Pasteur in Europe. [2] [24] Vaxigrip provides immune responses to three influenza strains and VaxigripTetra adds another B strain.

  5. www.ncbi.nlm.nih.gov › pmc › articlesStatement on Seasonal Trivalent Inactivated Influenza ...

    2010年8月8日 · The seasonal trivalent vaccine for 2010-2011 incorporates the pandemic 2009 influenza A (H1N1) (pH1N1) component, a new influenza A (H3N2) component and the same B component as last year.

    • This statement was prepared and approved by Naci.
    • 2010

  6. www.ktgh.com.tw › Medicament_tbDrug_Look【篤實 關懷 倫理 卓越】光田綜合醫院 Kuang Tien General Hospital

    VaxigripTetra尚無交互作用的研究，與其他疫苗同時接種的安全性資料尚未建立。依據Vaxigrip的臨床經驗，VaxigripTetra可以與其他疫苗同時接種。同時接種其他疫苗時，應使用不同注射器並於不同部位接種。 禁忌

  7. www.ncbi.nlm.nih.gov › pmc › articles4. A Novel Quadrivalent Inactivated Influenza Vaccine: ...

    2018年3月8日 · This review describes the results obtained from seven phase III clinical trials evaluating the immunogenicity, safety, and lot-to-lot consistency of a new quadrivalent split-virion influenza vaccine (Vaxigrip Tetra ®) formulated by adding a second B strain to the already licensed TIV.